By 2026, Bangladesh’s medical equipment and devices sector has grown into a USD 820 million market with a sustained 13% CAGR, making it one of South Asia’s most attractive investment destinations. Rising healthcare expenditure—up nearly 60% between 2015 and 2020—continues to fuel demand, while infrastructure has expanded dramatically with private hospitals increasing four‑fold to over 4,400, clinics tripling to nearly 1,400, dental clinics multiplying seven‑fold to more than 800, and diagnostic centers surging six‑fold to over 10,000. With around 85% of devices still imported, opportunities abound for global suppliers of advanced medical technologies, consumables, and diagnostics. Supported by government initiatives such as the Expanded Programme on Immunisation (EPI), which remains a flagship success, Bangladesh’s healthcare industry is rapidly modernizing, offering investors a compelling mix of strong demand, policy support, and strategic access to regional and global markets.